Envestnet Asset Management Inc. Reduces Holdings in Encompass Health Corporation $EHC

Envestnet Asset Management Inc. reduced its position in shares of Encompass Health Corporation (NYSE:EHC) by 6.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 350,785 shares of the company’s stock after selling 25,171 shares during the period. Envestnet Asset Management Inc. owned about 0.35% of Encompass Health worth $44,557,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Westside Investment Management Inc. grew its stake in shares of Encompass Health by 56.7% during the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after acquiring an additional 101 shares in the last quarter. Cornerstone Planning Group LLC boosted its holdings in Encompass Health by 800.0% in the third quarter. Cornerstone Planning Group LLC now owns 558 shares of the company’s stock valued at $65,000 after purchasing an additional 496 shares during the last quarter. Allianz Asset Management GmbH grew its stake in Encompass Health by 9.3% during the 3rd quarter. Allianz Asset Management GmbH now owns 502,746 shares of the company’s stock valued at $63,859,000 after purchasing an additional 42,741 shares in the last quarter. Bridges Investment Management Inc. purchased a new stake in Encompass Health during the 3rd quarter worth approximately $270,000. Finally, Jones Financial Companies Lllp raised its position in shares of Encompass Health by 42.9% in the 3rd quarter. Jones Financial Companies Lllp now owns 982 shares of the company’s stock valued at $124,000 after purchasing an additional 295 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC stock opened at $108.90 on Wednesday. The company has a market cap of $10.96 billion, a P/E ratio of 19.66, a PEG ratio of 2.05 and a beta of 0.73. The business has a 50 day moving average of $103.99 and a two-hundred day moving average of $114.50. Encompass Health Corporation has a 52 week low of $92.53 and a 52 week high of $127.99. The company has a quick ratio of 1.14, a current ratio of 1.08 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.29 by $0.17. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The business had revenue of $3.09 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter last year, the business posted $1.17 EPS. The business’s revenue was up 9.9% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Analyst Ratings Changes

A number of research firms have commented on EHC. Barclays increased their price objective on shares of Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research note on Friday. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Finally, Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, Encompass Health has an average rating of “Buy” and a consensus target price of $143.29.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.